ASPN has enough current analyst coverage to form a meaningful aggregate. Five recent targets stand out: Roth MKM at $7.75 (Buy), B. Riley Securities at $9.00 (Buy), TD Cowen at $7.00 (Buy), Craig-Hallum at $5.00 (Buy), and Barclays at $5.00 (Underweight). The arithmetic mean comes to about $6.75, which rounds neatly to the $7.00 central target, with the full range running from $5 to $9.
The spread here is unusually wide. Bulls such as B. Riley, which raised its target from $7 to $9 in August 2026, and Roth MKM, which lifted its figure from $5.75 to $7.75, highlight an earnings inflection and better visibility. Barclays has stayed more cautious, keeping an Underweight rating while nudging its target up from $4 to $5. The disagreement largely reflects differing assumptions about how quickly EV thermal-barrier demand and profitability will recover. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. The $7 figure is best viewed as a midpoint of genuinely divergent views rather than a firm prediction.
ASPN last closed near $4.91, so a move to $7.00 implies roughly 43% upside — a sizable required advance. The shares trade within a 52-week range of about $2.30 to $8.10, with a market capitalization near $408 million, and are up about 73% year to date.
The path toward the target would likely depend on the company sustaining its cost-cutting and returning to consistent positive adjusted EBITDA. Full-year 2025 revenue fell to about $271 million from roughly $453 million the prior year as EV thermal-barrier demand weakened, and trailing-twelve-month net income remains deeply negative. A credible recovery in revenue growth and margins, rather than valuation expansion alone, would be the more sustainable route toward the target.
Management guided third-quarter 2026 revenue of $65–$80 million and positive adjusted EBITDA of $7–$15 million, an inflection that several analysts cited when raising targets. Cost reductions, a dual-supply strategy, and an expected roughly $37.6 million General Motors settlement payment could strengthen the balance sheet. The Energy Industrial segment, serving refining, petrochemical, LNG, and power customers, provides diversification beyond EVs, while institutional ownership remains high and some funds added positions in 2026.
The biggest obstacle is demand: ASPN's Thermal Barrier segment depends heavily on EV battery production, which has been disrupted by changing North American regulations and incentives. Revenue has contracted sharply, and the company posted a trailing-twelve-month net loss of roughly $130 million. Customer concentration, potential further impairment or restructuring costs, and a beta near 3.07 mean the stock can fall quickly when sentiment turns. If EV thermal-barrier volumes disappoint again or the return to profitability slips, the bull case behind the higher targets weakens materially.
The stock sits below its 50-day moving average near $5.25, which now acts as near-term resistance, while the 200-day moving average near $4.67 offers support. The $5.00 round-number level is a key psychological zone, and the $8.10 52-week high represents a longer-term ceiling that would need to be cleared before the shares approach the $7 target on a durable basis.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual analysts may differ. Investors should watch quarterly revenue and adjusted EBITDA against guidance, progress on the General Motors settlement and the planned sale of Statesboro, Georgia facility assets, and any analyst target revisions. EV market conditions, tariff and incentive policy, and macroeconomic demand for industrial insulation are also central to the outlook.
The $7.00 central target, derived from five analyst price targets averaging about $6.75, requires roughly a 43% advance from the latest price near $4.91. The bull case rests on a guided return to positive adjusted EBITDA, cost discipline, and a General Motors settlement, while the bear case centers on contracting revenue, deep losses, and EV-demand uncertainty. With targets ranging from $5 to $9, the analyst community itself is divided, and no outcome is assured. The next earnings report, guidance updates, and any analyst revisions will be the most important signposts for whether the shares can build a durable path toward $7.
In my own research process, I often rely on Tickeron’s AI Daily Buy/Sell Signals to monitor names like ASPN. These signals use artificial intelligence to scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions and technical behavior. For a volatile stock such as this one, the tool helps separate meaningful changes from day-to-day noise and supports more disciplined decision-making around entry and exit points.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
On November 06, 2026, the Stochastic Oscillator for ASPN moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 62 instances where the indicator left the oversold zone. In 52 of the 62 cases the stock moved higher in the following days. This puts the odds of a move higher at over 84%.
Following a +6.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASPN advanced for three days, in 217 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
ASPN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day RSI Indicator for ASPN moved out of overbought territory on October 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 24 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 86%.
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ASPN as a result. In 75 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for ASPN turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 33 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 85%.
ASPN moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ASPN crossed bearishly below the 50-day moving average on November 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASPN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for ASPN entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 42 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.117) is normal, around the industry mean (2.284). P/E Ratio (-3.230) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (2.017) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. ASPN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASPN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of reinforced, nanoporous aerogel insulation products
Industry ChemicalsSpecialty